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Poster Presentations: P3 P679different levels of instrumental ADL (IADL) impairment at baseline, from
6.6 6 2.8 years (IADL score, 8-12) to 5.0 6 2.5 years (IADL score, 21-
31) (P< 0.001). The time from AD diagnosis to death also differed between
patients receiving antihypertensive/cardiac therapy (no/yes, 6.16 2.7 vs 5.3
6 2.8 years; P< 0.001), antidiabetics (no/yes, 5.86 2.8 vs 4.16 2.4 years;
P< 0.001), nonsteroidal anti-inflammatory drugs (NSAIDs)/acetylsalicylic
acid; no/yes, 6.0 6 2.8 vs 5.2 6 2.6 years;P < 0.001), and antipsychotics
(no/yes, 5.8 6 2.8 vs 4.7 6 2.5 years; P ¼ 0.020). IADL score at baseline
and antihypertensive/cardiac therapy, antidiabetics, and antipsychotics
were independent predictors of survival after AD diagnosis in a general
linear model, after controlling for sex, age, and cognitive ability. Basic
ADL, number of medications, and specific concomitant medications
(lipid-lowering agents, NSAIDs/acetylsalicylic acid, antidepressants, and
anxiolytics/sedatives/hypnotics) at baseline were not significant predictors.
Conclusions: IADL, but not basic ADL, was an important predictor that
should be considered by clinicians and community-based services when
estimating AD prognosis. Antidiabetic therapy was a strong risk factor for
reduction in life expectancy.
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Background: The AIBL study is following 1112 individuals (768 healthy
controls (HC), 133 with MCI and 211 with AD) prospectively, with cogni-
tive testing, imaging, health and lifestyle dataand biomarker assays every 18
months. We report transition rates to MCI and AD and the emergence of
other cognitive syndromes at 36 and 54 months of follow-up. Methods:
Every 18 months participants undertook detailed cognitive assessment,
completed health and lifestyle questionnaires and gave 80 ml of blood.
Initially one quarter underwent amyloid and MRI brain imaging at baseline
and every follow-up. Results: At 36 months 74.1 % (824) returned for
assessment. Since baseline 73 had died and 215 did not return. At 36 months
610 were classified as HC, 56 as MCI and 154 as AD. There were 3 cases of
vascular dementia and one of dementia due to Parkinson’s disease. At 54
months 718 (64.6%) could have their diagnostic status determined, with
294 having withdrawn and 100 having died. There were 560 HCs, 51
MCIs, 102 ADs and 5 non-AD dementia cases at 54 months. HCs transi-
tioned to MCI or AD at a rate of 4.6% by 36 and 6.6 by 54 months. At 36
months 35.3% of MCIs had developed AD. Conclusions: Perhaps because
the baseline HCs were well educated, healthy and with an average age of 70
at baseline, transition to MCI or AD from this group has been slow to date,
but the development of AD in our MCI cohort has been within expected par-
amaters. Having AD or MCI was associated with an increased risk of death
or drop out. We are currently collecting 72 month data and have expanded
the cohort to compensate for thos who dropped out.
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Background: General practitioners (GPs) may be good at diagnosing de-
mentia but poor at documenting the diagnosis, creating a barrier for appro-
priate management. In regional areas the GP is often the most accessible
doctor, and patients may expect them to identify and manage this condition.
The objective of this study was to test education and audit as interventions to
improve documentation of dementia diagnoses by GPs. Methods: Thedesign was multi-centered with clusters of GPs at 16 locations randomized
using Excel software into one of four groups, three intervention and one con-
trol. The intervention applied separately and together, consisted of educa-
tion - a workshop on GP dementia guidelines, and audit - the proportion
of documented dementia diagnoses in patients aged 65 years and over
compared with a predicted prevalence of 5% in this age group. The setting
was Regional North-Queensland, Australia, spanning 1000 km. Participants
were 56 GPs (8% of GP population) from 27 practices, 55$ with over 20
years in practice, 33% female, 57% International Medical Graduates. The
outcome measures were the change in audit at 0 and 6 months of the trial.
Multivariate linear regression analysis measured the effect on this outcome
of independent variables consisting of the interventions applied separately
and together, years in practice and International medical training. Results:
61 GPs entered the trial with 56 completing. Five withdrew due to work
commitments or relocation. Over 10,000 patient files provided data for au-
dits. Analysis was performed on two data set; intention to treat - all
completing GPs (n¼56), and per protocol - GPs providing individual data
who complied with their intervention (n¼37). Audit significantly increased
documentation in the smaller sample (p¼0.017) but not in the larger
(p¼0.50). Education had no significant effect. Combining education and
audit did not increase the treatment effect. Neither ’over twenty years in
practice’ nor ’international medical training’ significantly influenced the
outcome. Conclusions: The intention to treat analysis produced no signifi-
cant outcomes possibly due to poor protocol compliance. However, per pro-
tocol analysis suggested that audit might increase GP documentation of
dementia diagnoses while education may not.
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Background: Interpretation of neuropsychiatric symptoms in Alzheimer’s
disease (AD) represents a critical strategy to appropriately diagnose and
treat the patients. To improve the accuracy of recognition of psychopatho-
logical manifestations remains a challengeable issue. Aims: To analyze dis-
agreements between caregiver and clinician with regard to recognizing
neuropsychiatric manifestations of AD patients.Methods:We analyzed in-
terpretations of neuropsychiatric manifestations in 156 caregivers respon-
sible for their respective 156 AD patients. We compared caregiver report
with clinician impression concerning all domains from the Neuropsychiatric
Inventory-Clinician Rating Scale (NPI-C). Results:We observed important
disagreements in recognizing for the majority of neuropsychiatric domains
when we compared caregiver report with clinician impression in the same
patient. Apathy/Indifference, Agitation, Anxiety, and Depression were do-
mains with higher disagreements in interpreting psychopathological symp-
tomatology, while Hallucinations and Elation/Euphoria were domains with
lower disagreements (Table). Conclusions: Disagreements between care-
giver report and clinician impression concerning interpretation of neuropsy-
chiatric symptoms in AD patients reflect a requirement for accurate
